T-Cypher Bio
Pre-clinicalAt T-Cypher, we develop drugs against novel disease-specific targets to improve the lives of patients with cancer and autoimmune diseases.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $18M
About
At T-Cypher, we develop drugs against novel disease-specific targets to improve the lives of patients with cancer and autoimmune diseases.
Biologics
Funding History
1Total raised:$18M
Seed$18MJun 15, 2022